Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Genitourinary Cancer|February 28, 2019
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative AnalysisCharles A Field, Brittney H Cotta, Juan Jimenez, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/DocetaxelKendrick Yim, Matias Vergara, Jihyun Lee, et al.Clinical Genitourinary Cancer|August 9, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter AnalysisKevin Hakimi, Ava Saidian, Justine Panian, et al.European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.Clinical Genitourinary Cancer|July 1, 2020
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional AnalysisSunil H Patel, Robert G Uzzo, Alessandro Larcher, et al.European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.European Urology Focus|November 29, 2020
Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter AnalysisKendrick Yim, Monish Aron, Koon H Rha, et al.The Oncologist|June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following ImmunotherapyJustine Panian, Ava Saidian, Kevin Hakimi, et al.Clinical Genitourinary Cancer|April 26, 2025
Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell CarcinomaCesare Saitta, Riccardo Autorino, Umberto Capitanio, et al.Pageof 3